Showing 1 - 4 results of 4 for search 'Steinar Aamdal', query time: 0.02s Refine Results
  1. 1
    Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

    Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials by Sara M Mangsbo, Eivind Hovig, Nadia Mensali, Else Marit Inderberg, Steinar Aamdal, Elin Aamdal, Tormod Guren, Gustav Gaudernack, Espen Basmo Ellingsen, Wolfgang Lilleby, Paal F Brunsvig

    Published 2022-05-01
    Get full text
    Article
  2. 2
    382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanoma

    382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patient... by Sara Mangsbo, Eivind Hovig, Nadia Mensali, Espen Ellingsen, Iliana Kerzeli, Irantzu Anzar, Trevor Clancy, Steinar Aamdal, Elin Aamdal, Tormod Guren, Else-Marit Inderberg-Suso, Gustav Gaudernack

    Published 2021-11-01
    Article
  3. 3
    Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer

    Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer by Paal F. Brunsvig, Tormod Kyrre Guren, Marta Nyakas, Claudius H. Steinfeldt-Reisse, Wenche Rasch, Jon Amund Kyte, Hedvig Vidarsdotter Juul, Steinar Aamdal, Gustav Gaudernack, Else Marit Inderberg

    Published 2020-11-01
    Get full text
    Article
  4. 4
    Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 “CREATE” Trial

    Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 “CREATE” Trial by Che-Jui Lee, Elodie Modave, Bram Boeckx, Bernd Kasper, Steinar Aamdal, Michael G. Leahy, Piotr Rutkowski, Sebastian Bauer, Maria Debiec-Rychter, Raf Sciot, Diether Lambrechts, Agnieszka Wozniak, Patrick Schöffski

    Published 2022-05-01
    Get full text
    Article

Search Tools: